β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

Vancomycin (VAN) is often used to treat methicillin-resistant Staphylococcus aureus (MRSA) bacteremia despite a high incidence of microbiological failure. Recent in vitro analyses of β-lactams in combination with VAN demonstrated synergistic activity against MRSA. The goal of this study was to exami...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Dilworth, Thomas J., Ibrahim, Omar, Hall, Pamela, Sliwinski, Jora, Walraven, Carla, Mercier, Renée-Claude
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2014
Предметы:
Clinical Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910806/
https://ncbi.nlm.nih.gov/pubmed/24145519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01204-13
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы